Exiqon announces launch of 6th generation of miRCURY LNA microRNA Arrays

NewsGuard 100/100 Score

Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 6th generation of miRCURY LNA™ microRNA Arrays for expression profiling of microRNA from human, mouse and rat.

The new microRNA arrays have 2361 unique capture probes covering all mature human (1223), mouse (1055), rat (680) and related viral (human 146, mouse 57) microRNA sequences as annotated in miRBase v16.0. This is an increase of 500 microRNA capture probes compared with the 5th generation microRNA Array. The array also contains capture probes for 66 proprietary miRPlus™ microRNAs.

"With the new and updated array we strengthen our position as the leading provider of microRNA products", said Vice President Sales & Marketing Henrik M. Pfundheller and added: "Our 6th generation microRNA array offers by far the broadest and most updated coverage of miRBase 16 on the market with capture probes for more than 25% additional human microRNA compared to our competitors".

The miRCURY LNA™ microRNA Array, 6th gen - hsa, mmu & rno microarray, is the most sensitive microRNA array available today with required sample input of as little as 30 ng of total RNA. It is possible to detect down to 10 copies of microRNAs from a biological sample.

Exiqon also recently announced the selection of its microRNA array by a multinational company as the most sensitive and specific platform compared to a main competitor.

The 6th generation of miRCURY LNA™ microRNA Arrays are fully compatible with Exiqon's miRCURY LNA™ Universal RT microRNA PCR product line which customers use to validate expression profiles obtained by the miRCURY LNA™ microRNA Arrays.

Source:

Exiqon A/S

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers elucidate how gene mutation mechanism causes autism